Lung PD-L1 AI is an automated, AI-based decision-support tool that standardizes scoring of PD-L1 IHC in non-small cell lung cancer (NSCLC) on whole slide images (WSI) in accordance with clinical scoring guidelines. Lung PD-L1 AI is seamlessly integrated into the HALO AP® diagnostic digital pathology platform.
SlideQC BF for HALO AP® is an automated, AI-powered application for H&E stained digitized slides that detects the most common artifacts including air bubbles, dust/debris, folds, out-of-focus areas, and pen marks generated during the process of slide preparation and whole slide imaging. It is seamlessly integrated into the HALO AP diagnostic digital pathology platform.
30 November 2023 | Learn how to implement Lung PD-L1 AI to assist PD-L1 scoring in non-small cell lung cancer
28 September 2023 | Please join us for this 1-hour webinar to learn about the exciting new features of our AI-powered, pathologist-driven digital pathology platform, HALO AP, and our Breast IHC AI suite
HALO AP is an AI-powered, pathologist-driven diagnostic pathology platform that brings together patient data, whole slide images, and AI-based decision support tools to enable remote working, primary diagnosis, and other routine workflows in anatomic pathology.
HALO Prostate AI, from Indica Labs, is a CE-IVD certified deep learning based screening tool designed to assist pathologists in the identification and grading of prostate cancer in core needle biopsies.
